Key Insights

Highlights

Success Rate

79% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

12.8%

6 terminated out of 47 trials

Success Rate

79.3%

-7.2% vs benchmark

Late-Stage Pipeline

17%

8 trials in Phase 3/4

Results Transparency

35%

8 of 23 completed with results

Key Signals

8 with results79% success

Data Visualizations

Phase Distribution

37Total
Not Applicable (23)
P 1 (2)
P 2 (4)
P 3 (2)
P 4 (6)

Trial Status

Completed23
Recruiting7
Unknown7
Terminated6
Not Yet Recruiting3
Withdrawn1

Trial Success Rate

79.3%

Benchmark: 86.5%

Based on 23 completed trials

Clinical Trials (47)

Showing 20 of 20 trials
NCT07194187Not ApplicableNot Yet Recruiting

High Intensity Focused Ultrasound (HIFU) Ablation for Treatment of Prostate Tissue in Bladder Outlet Obstruction

NCT07381127Not ApplicableRecruiting

INTUPRO in the Treatment of Benign Prostatic Hyperplasia-Related Symptoms

NCT05914519Not ApplicableCompleted

Outcomes and Efficacy of Ejaculatory Preserving Transurethral Resection of Prostate

NCT06323109Recruiting

US Imaging for the Assessment of LUTS

NCT06351579Completed

Data Collection Post Radical Prostatectomy

NCT07115147Not ApplicableRecruitingPrimary

Blue Diode Laser Vaporization for BPH

NCT05719220RecruitingPrimary

Effect of Group Preoperative Pelvic Floor Training for HoLEP

NCT05401032Phase 2RecruitingPrimary

Proof-of-concept Study to Evaluate the Safety and Efficacy of Tryptophan in Patients with BPH.

NCT04826887CompletedPrimary

SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia

NCT06550960Not ApplicableNot Yet RecruitingPrimary

Evaluation of SureCore Plus Biopsy System

NCT03912558Not ApplicableCompletedPrimary

Pilot Study to Assess the Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in BPH Patients.

NCT05910983Not ApplicableNot Yet RecruitingPrimary

Prostate Enucleation With Intravesical Botox Injections in Treating BPH and Bladder Overactivity

NCT04398966Not ApplicableTerminatedPrimary

Prostatic Artery Embolization vs Medication for Benign Prostatic Hyperplasia

NCT03131544Not ApplicableCompletedPrimary

MRI Guided Transrectal Prostate Laser Ablation for Benign Prostatic Hypertrophy (BPH)

NCT02876757CompletedPrimary

5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression

NCT03395522Not ApplicableUnknownPrimary

Study to Assess the Efficacy of the iTind in Subjects With Symptomatic BPH

NCT05620784Phase 3Recruiting

Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP

NCT05330520Not ApplicableRecruitingPrimary

Long Term Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in Benign Prostatic Hyperplasia (BPH) Patients Who Completed 12 Months of Follow-Up Post Implantation (Continuation Study for Study BM-011-IL)

NCT04987892Phase 4UnknownPrimary

Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH

NCT05818670Phase 4CompletedPrimary

Comparison Between Tamsulosin and Tadalafil in Management of Benign Prostatic Hyperplasia Long Term Study

Scroll to load more

Research Network

Activity Timeline